UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy

Antimicrobial agents and chemotherapy, 2018-01, Vol.62 (1)

2018

Volltextzugriff (PDF)

Review article: clinical pharmacology of current and investigational hepatitis B virus therapies

Alimentary pharmacology & therapeutics, 2020-01, Vol.51 (2), p.231-243

2020

Volltextzugriff (PDF)

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection

Annual review of pharmacology and toxicology, 2013-01, Vol.53 (1), p.427-449

2013

Volltextzugriff (PDF)

Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions

World journal of gastroenterology : WJG, 2017-03, Vol.23 (9), p.1618-1626

2017

Volltextzugriff (PDF)

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

AIDS research and human retroviruses, 2013-02, Vol.29 (2), p.384-390

2013

Volltextzugriff (PDF)

Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots

Journal of pharmaceutical and biomedical analysis, 2016-04, Vol.122, p.16-20

2016

Volltextzugriff (PDF)

Drug-drug interactions during antiviral therapy for chronic hepatitis C

Nature reviews. Gastroenterology & hepatology, 2013-10, Vol.10 (10), p.596-606

2013

Volltextzugriff (PDF)

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study

Journal of acquired immune deficiency syndromes (1999), 2020-07, Vol.84 (3), p.323-330

2020

Volltextzugriff (PDF)

Effect of Disease Pathologies on Transporter Expression and Function

Journal of clinical pharmacology, 2016-07, Vol.56 (S7), p.S205-S221

2016

Volltextzugriff (PDF)

Plasma and Intracellular Population Pharmacokinetic Analysis of Tenofovir in HIV-1-Infected Patients

Antimicrobial Agents and Chemotherapy, 2011-11, Vol.55 (11), p.5294-5299

2011

Volltextzugriff (PDF)

Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State

AIDS research and human retroviruses, 2016-11, Vol.32 (10-11), p.981-991

2016

Volltextzugriff (PDF)

Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers

Journal of acquired immune deficiency syndromes (1999), 2008-04, Vol.47 (5), p.570-578

2008

Volltextzugriff (PDF)

Safety of Hepatitis C Viral Protease Inhibitors in Compensated Cirrhotics: Lingering Concerns Put to Rest?

Clinical infectious diseases, 2019-10, Vol.69 (10), p.1665-1666

Kiser, Jennifer J

2019

Volltextzugriff (PDF)

Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates

PloS one, 2016-11, Vol.11 (11), p.e0165505

2016

Volltextzugriff (PDF)

Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?

Antimicrobial Agents and Chemotherapy, 2013-11, Vol.57 (11), p.5619-5628

2013

Volltextzugriff (PDF)

Serum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin

Journal of antimicrobial chemotherapy, 2015-08, Vol.70 (8), p.2322-2329

2015

Volltextzugriff (PDF)

Prospects for Long-Acting Treatments for Hepatitis C

Clinical infectious diseases, 2022-11, Vol.75 (Suppl 4), p.S525-S529

2022

Volltextzugriff (PDF)

Effect of Antacids on the Pharmacokinetics of Raltegravir in Human Immunodeficiency Virus-Seronegative Volunteers

Antimicrobial Agents and Chemotherapy, 2010-12, Vol.54 (12), p.4999-5003

2010

Volltextzugriff (PDF)

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States

JAMA pediatrics, 2017-11, Vol.171 (11), p.1063

2017

Volltextzugriff (PDF)

Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz

Infectious Diseases in Obstetrics and Gynecology, 2012, Vol.2012 (2012), p.23-26

2012

Volltextzugriff (PDF)

The use of technology-based adherence monitoring in the treatment of hepatitis C virus

Therapeutic Advances in Infectious Disease, 2022, Vol.9

2022

Volltextzugriff (PDF)

Long-Acting Treatments for Hepatitis B

Clinical infectious diseases, 2022-11, Vol.75 (Suppl 4), p.S517-S524

2022

Volltextzugriff (PDF)

Antiviral Treatment Failures After Transplantation of Organs From Donors With Hepatitis C Infection: A Report of 4 Cases

American journal of kidney diseases, 2023-09, Vol.82 (3), p.368-372

2023

Volltextzugriff (PDF)

Review and management of drug interactions with boceprevir and telaprevir

Hepatology (Baltimore, Md.), 2012-05, Vol.55 (5), p.1620-1628

2012

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(127)
Mit Volltextzugriff
(140)

Publikationsform

Artikel
(131)
Buchkapitel
(32)
Bücher
(4)
Berichte
(2)

Sprache

Englisch
(169)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy

Review article: clinical pharmacology of current and investigational hepatitis B virus therapies

Direct-Acting Antiviral Agents for Hepatitis C Virus Infection

Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions

Tenofovir, emtricitabine, and tenofovir diphosphate in dried blood spots for determining recent and cumulative drug exposure

Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots

Drug-drug interactions during antiviral therapy for chronic hepatitis C

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study

Effect of Disease Pathologies on Transporter Expression and Function

Plasma and Intracellular Population Pharmacokinetic Analysis of Tenofovir in HIV-1-Infected Patients

Intracellular Tenofovir and Emtricitabine Anabolites in Genital, Rectal, and Blood Compartments from First Dose to Steady State

Drug/Drug interaction between lopinavir/ritonavir and rosuvastatin in healthy volunteers

Safety of Hepatitis C Viral Protease Inhibitors in Compensated Cirrhotics: Lingering Concerns Put to Rest?

Model Linking Plasma and Intracellular Tenofovir/Emtricitabine with Deoxynucleoside Triphosphates

Association of Higher Plasma Vitamin D Binding Protein and Lower Free Calcitriol Levels with Tenofovir Disoproxil Fumarate Use and Plasma and Intracellular Tenofovir Pharmacokinetics: Cause of a Functional Vitamin D Deficiency?

Serum and cellular ribavirin pharmacokinetic and concentration-effect analysis in HCV patients receiving sofosbuvir plus ribavirin

Prospects for Long-Acting Treatments for Hepatitis C

Effect of Antacids on the Pharmacokinetics of Raltegravir in Human Immunodeficiency Virus-Seronegative Volunteers

Safety and Feasibility of Antiretroviral Preexposure Prophylaxis for Adolescent Men Who Have Sex With Men Aged 15 to 17 Years in the United States

Pharmacokinetic Interactions between the Hormonal Emergency Contraception, Levonorgestrel (Plan B), and Efavirenz

The use of technology-based adherence monitoring in the treatment of hepatitis C virus

Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

Long-Acting Treatments for Hepatitis B

Antiviral Treatment Failures After Transplantation of Organs From Donors With Hepatitis C Infection: A Report of 4 Cases

Review and management of drug interactions with boceprevir and telaprevir

Suchergebnisse filtern